Myths and facts about the EARLYSTIM study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Movement Disorders

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mds.26080PMID 25399678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Subthalamic nucleus deep brain stimulation in early stage Parkinson's disease.

  2014cited by this paper
• Another face of placebo: The lessebo effect in Parkinson disease

  2014cited by this paper
• Subthalamic neurostimulation for Parkinson's disease with early fluctuations: balancing the risks and benefits.

  2013influential reference
• Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study.

  2013cited by this paper
• A second honeymoon for Parkinson's disease?

  2013cited by this paper
• Neurostimulation for Parkinson's disease with early motor complications.

  2013cited by this paper
• Parkinson Subtypes Progress Differently in Clinical Course and Imaging Pattern

  2012cited by this paper
• Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.

  2012cited by this paper
• Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses.

  2010cited by this paper
• Microsubthalamotomy effect at day 3: Screening for determinants

  2009cited by this paper
• Progression of Parkinson's disease in the clinical phase: potential markers.

  2009cited by this paper
• Neurosurgery at an earlier stage of Parkinson disease: A randomized, controlled trial

  2008cited by this paper
• Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

  2008cited by this paper
• Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions

  2008cited by this paper
• Effect of medical and surgical interventions on health‐related quality of life in Parkinson's disease

  2007cited by this paper
• Neurosurgery at an earlier stage of Parkinson disease

  2007cited by this paper
• Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.

  2007cited by this paper
• A randomized trial of deep-brain stimulation for Parkinson's disease.

  2006cited by this paper
• Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease

  2006influential reference
• Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.

  2006cited by this paper
• Minimal clinically important change on the unified Parkinson's disease rating scale

  2006influential reference
• Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease.

  2006cited by this paper
• Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.

  2005cited by this paper
• Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease.

  2004influential reference
• Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial.

  2004cited by this paper
• How do parkinsonian signs return after discontinuation of subthalamic DBS?

  2003cited by this paper
• Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  2003cited by this paper
• Functional anatomy of the basal ganglia

  2002cited by this paper
• The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

  2002cited by this paper
• Functional decline in Parkinson disease.

  2001influential reference
• Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

  2001cited by this paper
• Objective changes in motor function during placebo treatment in PD

  2000cited by this paper
• [Functional anatomy of the basal ganglia].

  2000cited by this paper
• Progression of parkinsonian signs in Parkinson disease.

  1999cited by this paper
• Stereotaxis in Parkinson Syndrome

  1979cited by this paper

• Deep Brain Stimulation in Movement Disorders

  2026cites this paper
• Patient, target, device, and program selection for DBS in Parkinson’s disease: advancing toward precision care

  2025cites this paper
• Placebo Responses in Trials of Parkinson's Disease.

  2025cites this paper
• Effects of deep brain stimulation and verbal suggestions on pain in Parkinson’s disease

  2024cites this paper
• Deep brain stimulation in Dopa-Responsive Parkinsonism - Look out for red flags: Expert commentary.

  2023cites this paper
• Deep brain stimulation in Parkinson's disease with valosin-containing protein gene mutation.

  2023cites this paper
• Neurologists' Attitudes Toward Use and Timing of Deep Brain Stimulation

  2021cites this paper
• Deep Brain Stimulation for Preclinical and Prodromal Alzheimer’s Disease: Integrating Beneficence, Non-Maleficence, and Autonomy Considerations Through Responsible Innovation

  2021cites this paper
• Neurosurgeons perspective on the shift towards earlier use of deep brain stimulation for parkinson disease

  2021cites this paper
• Capturing Initial Understanding and Impressions of Surgical Therapy for Parkinson's Disease

  2021cites this paper
• Clinical Trials for Motor Complications in Parkinson’s Disease

  2021cites this paper
• Clinical Trials In Parkinson's Disease

  2021cites this paper
• Ethical and Legal Issues in Deep Brain Stimulation: An Overview

  2020cites this paper
• Deep Brain Stimulation for Parkinson's Disease: Currents Status and Emerging Concepts

  2020cites this paper
• Deep Brain Stimulation Selection Criteria for Parkinson’s Disease: Time to Go beyond CAPSIT-PD

  2020cites this paper
• DBS: a compelling example for ethical and legal reflection—a French perspective on ethical and legal concerns about DBS

  2020cites this paper
• Clinical Trials for in Parkinson’s

  2020cites this paper
• DBS: a compelling example for ethical and legal reflection—a French perspective on ethical and legal concerns about DBS

  2020cites this paper
• Indicación de estimulación cerebral profunda en casos complejos de enfermedad de Parkinson. Experiencia en el Hospital Clínico Universidad de Chile

  2020cites this paper
• Interpretation of health-related quality of life outcomes in Parkinson’s disease from the EARLYSTIM Study

  2020cites this paper
• The effects of deep-brain non-stimulation in severe obsessive-compulsive disorder: an individual patient data meta-analysis

  2019cites this paper
• An update on best practice of deep brain stimulation in Parkinson’s disease

  2019cites this paper
• Mapping the experiences and needs of deep brain stimulation for people with Parkinson’s disease and their family members

  2019cites this paper
• Changes in Personality Associated with Deep Brain Stimulation: a Qualitative Evaluation of Clinician Perspectives

  2019cites this paper
• Cognitive aspects of deep brain stimulation - A five-year follow-up study of patients with Parkinson’s disease

  2019cites this paper
• Decision under risk: Argument against early deep brain stimulation in Parkinson's disease.

  2019cites this paper
• Understanding the impact of subthalamic deep brain stimulation on cognitive and affective processing

  2019cites this paper
• Functional neurosurgery in Parkinson’s disease in Russia

  2019cites this paper
• Computationally Developed Sham Stimulation Protocol for Multichannel Desynchronizing Stimulation

  2018cites this paper
• Patient’s lived experience with DBS between medical research and care: some legal implications

  2018cites this paper
• Deep Brain Stimulation in Parkinson's Disease

  2018cites this paper
• Subthalamic Stimulation Improves Quality of Life of Patients Aged 61 Years or Older With Short Duration of Parkinson's Disease

  2018cites this paper
• What influences placebo and nocebo responses in Parkinson's disease?

  2018cites this paper
• Modern Aspects of Surgical Neuromodulation

  2018cites this paper
• Are Patients Ready for “EARLYSTIM”? Attitudes towards Deep Brain Stimulation among Female and Male Patients with Moderately Advanced Parkinson's Disease

  2017cites this paper
• Ablative surgery for Parkinson's disease: Is there still a role for pallidotomy in the deep brain stimulation era?

  2017cites this paper
• Subthalamic nucleus stimulation impairs emotional conflict adaptation in Parkinson’s disease

  2017cites this paper
• Chapter 49 – Deep-Brain Stimulation for Neurologic and Neuropsychiatric Disorders

  2017cites this paper
• Earlier Intervention with Deep Brain Stimulation for Parkinson's Disease

  2017cites this paper
• Current Topics in Deep Brain Stimulation for Parkinson Disease

  2016cites this paper
• Deep brain stimulation for Parkinson's disease prior to L-dopa treatment: A case report

  2016cites this paper
• Factors influencing the outcome of deep brain stimulation: Placebo, nocebo, lessebo, and lesion effects

  2016cites this paper
• Pallidal stimulation in dystonia affects cortical but not spinal inhibitory mechanisms.

  2016cites this paper
• Referring Parkinson’s disease patients for deep brain stimulation: a RAND/UCLA appropriateness study

  2015cites this paper
• Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.

  2015cites this paper
• Avaliação quantitativa dos efeitos da levodopa e da estimulação do núcleo subtalâmico sobre o equilíbrio em pacientes com doença de Parkinson

  2015cites this paper
• Suicidal behaviors are very rare in antiparkinsonian drug trials.

  2015cites this paper
• Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards.

  2015cites this paper
• Deep Brain Stimulation Can Preserve Working Status in Parkinson's Disease

  2015cites this paper
• Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?

  2015cites this paper